An open-label, multicenter, phase Ib study to evaluate RC48-ADC in patients with HER2-positive metastatic breast cancer.

出版年份 2018 全文链接

标题

作者

关键词

出版物

Volume 36, Issue 15_suppl, Pages 1028-1028

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2018-09-05

DOI

10.1200/jco.2018.36.15_suppl.1028

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discuss science. Find collaborators. Network.

Join a conversation